-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $140

Benzinga·07/13/2026 15:43:18
Listen to the news
JP Morgan analyst Chris Schott maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $135 to $140.